{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:39:21Z","timestamp":1780637961522,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaci.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:17:52Z","timestamp":1718986672000},"page":"1044-1059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Human angiotensin-converting enzyme 2\u2013specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1286-7676","authenticated-orcid":false,"given":"Tong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sadewasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Reyes","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Raith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jaschinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-7475","authenticated-orcid":false,"given":"Weiping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.06.007_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2471\/BLT.20.267112","article-title":"Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study","volume":"99","author":"Jin","year":"2021","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2024.06.007_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib4","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2024.06.007_bib5","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq1841","article-title":"Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure","volume":"377","author":"Reynolds","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.06.007_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.06.007_bib12","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2024.06.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003232","article-title":"TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine","volume":"9","author":"Jemielity","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2024.06.007_bib14","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2024.06.007_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2024.06.007_bib16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1473-3099(21)00262-0","article-title":"SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity","volume":"21","author":"Ramanathan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2024.06.007_bib18","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2024.06.007_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41588-021-01006-7","article-title":"Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease","volume":"54","author":"Horowitz","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.06.007_bib21","article-title":"Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions","volume":"2","author":"Filbin","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib22","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jaci.2024.06.007_bib23","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","article-title":"Angiotensin-converting enzyme II in the heart and the kidney","volume":"98","author":"Danilczyk","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.7150\/ijms.46695","article-title":"A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells","volume":"17","author":"Wang","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jaci.2024.06.007_bib26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib28","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148517","article-title":"Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19","volume":"131","author":"Ahn","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jaci.2024.06.007_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2024.06.007_bib31","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/nar\/gky145","article-title":"Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib32","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/nar\/gkv143","article-title":"Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages","volume":"43","author":"Liang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0300-9084(02)01459-1","article-title":"Developments in RNA chemistry, a personal view","volume":"84","author":"Eckstein","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.jaci.2024.06.007_bib34","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonucleotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2024.06.007_bib35","first-page":"7314","article-title":"Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib36","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","author":"Stein","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib37","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI117860","article-title":"Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides","volume":"95","author":"Beltinger","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jaci.2024.06.007_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2024.06.007_bib39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2024.06.007_bib40","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/bioinformatics\/btn223","article-title":"PatMaN: rapid alignment of short sequences to large databases","volume":"24","author":"Pr\u00fcfer","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2024.06.007_bib41","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1093\/nar\/gku142","article-title":"Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides","volume":"42","author":"Burdick","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib42","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1093\/nar\/gkg580","article-title":"OligoDesign: optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling","volume":"31","author":"Tolstrup","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib43","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.omtn.2019.04.018","article-title":"Anti-Niemann Pick C1 single-stranded oligonucleotides with locked nucleic acids potently reduce Ebola virus infection in\u00a0vitro","volume":"16","author":"Sadewasser","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jaci.2024.06.007_bib44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","article-title":"Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection","volume":"36","author":"Cimolai","year":"1992","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jaci.2024.06.007_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.06.007_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","article-title":"Safety of antisense oligonucleotide and siRNA-based therapeutics","volume":"22","author":"Chi","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jaci.2024.06.007_bib48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0192623315570341","article-title":"Scientific and Regulatory Policy Committee Points-to-consider Paper\u2217: drug-induced vascular injury associated with nonsmall molecule therapeutics in preclinical development, part 2: antisense oligonucleotides","volume":"43","author":"Engelhardt","year":"2015","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jaci.2024.06.007_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40824-022-00292-4","article-title":"Nonviral delivery systems for antisense oligonucleotide therapeutics","volume":"26","author":"Huang","year":"2022","journal-title":"Biomater Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2024.06.007_bib52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/v13030392","article-title":"SARS-CoV-2 variant of concern 202012\/01 has about twofold replicative advantage and acquires concerning mutations","volume":"13","author":"Grabowski","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jaci.2024.06.007_bib53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMc2107799","article-title":"Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants","volume":"385","author":"Edara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2024.06.007_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02186-21","article-title":"Rapid SARS-CoV-2 adaptation to available cellular proteases","volume":"96","author":"Chaudhry","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2024.06.007_bib58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2024.06.007_bib59","doi-asserted-by":"crossref","unstructured":"Mori Y, Fink C, Ichimura T, Sako K, Mori M, Lee NN, et\u00a0al. KIM-1\/TIM-1 is a receptor for SARS-CoV-2 in lung and kidney [preprint January 11, 2022]. medRxiv. https:\/\/doi.org\/10.1101\/2020.09.16.20190694.","DOI":"10.1101\/2020.09.16.20190694"},{"key":"10.1016\/j.jaci.2024.06.007_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.06.007_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jaci.2024.06.007_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaci.2024.06.007_bib63","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib64","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/22221751.2021.1956373","article-title":"Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor","volume":"10","author":"Guo","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jaci.2024.06.007_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281281","article-title":"Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection","volume":"18","author":"Qiao","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2024.06.007_bib66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2024.06.007_bib67","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.06.007_bib68","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"Yeung","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2024.06.007_bib69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","article-title":"ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.06.007_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41392-022-00913-3","article-title":"ACE2-targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants","volume":"7","author":"Ou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.06.007_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924006316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924006316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T14:48:35Z","timestamp":1728226115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924006316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0091674924006316"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.06.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human angiotensin-converting enzyme 2\u2013specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}